Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
|
662.7000 -4.70 (-0.70%)
NSE Dec 30, 2025 15:31 PM
Volume: 74,468
 

logo
Rubicon Research Ltd.
18 Nov 2025
662.70
-0.70%

Outperformance across metrics; stellar start to the post-IPO phase

buy
by Motilal Oswal
Target: 780
Motilal Oswal
Rubicon Research (Rubicon) delivered better-than-expected performance, with a 7%/18%/21% beat on revenue/EBITDA/PAT for the quarter.
 
Rubicon Research Ltd. has an average target of 780.00 from 5 brokers.
More from Rubicon Research Ltd.
Recommended
Market closes flat as gains in metal & auto stocks offset losses in other sectors
Trendlyne Marketwatch | 30 Dec 2025, 04:11PM
IPO activity is high on listings, but low on subscriptions
| 29 Dec 2025, 05:02PM
Five Interesting Stocks Today - December 26, 2025
The Baseline | 26 Dec 2025